Galanta Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
as on 09-12-2024
- Paid Up Capital ₹ 0.66 M
as on 09-12-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
- Revenue 56.75%
(FY 2018)
- Profit 86.22%
(FY 2018)
- Ebitda 68.84%
(FY 2018)
- Net Worth 119.96%
(FY 2018)
- Total Assets 20.50%
(FY 2018)
About Galanta Pharma
The Corporate was formerly known as Flavine Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.66 M, as per Ministry of Corporate Affairs (MCA) records.
Gerd Weithase and Sunyog Chauhan serve as directors at the Company.
- CIN/LLPIN
U24232HR2009PTC039182
- Company No.
039182
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2009
- Date of AGM
27 Jun 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Galanta Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gerd Weithase  | Director | 05-Jun-2009 | Current |
Sunyog Chauhan  | Director | 05-Jun-2009 | Current |
Financial Performance of Galanta Pharma.
Galanta Pharma Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 56.75% increase. The company also saw a substantial improvement in profitability, with a 86.22% increase in profit. The company's net worth Soared by an impressive increase of 119.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Galanta Pharma?
In 2018, Galanta Pharma had a promoter holding of 99.98% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Galanta Pharma?
Unlock and access historical data on people associated with Galanta Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galanta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galanta Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
